Deschavannes Arnaud, Piquemal Marie, Rioufol Catherine, Clotagatide Anthony
Radiopharmacy Unit, Department of Pharmacy, Groupement Hospitalier Sud - Hospices Civils de Lyon, 165 chemin du Grand Revoyet, 69495, Pierre-Bénite, France; Department of Pharmacy - Groupement Hospitalier Sud - Hospices Civils de Lyon, 165 chemin du Grand Revoyet, 69495, Pierre-Bénite, France.
Department of Pharmacy - Groupement Hospitalier Sud - Hospices Civils de Lyon, 165 chemin du Grand Revoyet, 69495, Pierre-Bénite, France.
Appl Radiat Isot. 2025 Mar;217:111627. doi: 10.1016/j.apradiso.2024.111627. Epub 2024 Dec 14.
For hepatobiliary scintigraphy, the radiopharmaceutical drug, ETIFENIN (TECHIDA®), labelled with technetium-99m, is used as a substitute for MEBROFENIN (CHOLEDIAM®). It is generally accepted that radiopharmaceuticals should be checked prior to injection, in particular by determining radiochemical purity, to ensure high-quality images. Radiochromatographic techniques or methods described in the Summary of Product Characteristics (SmPC) and the European Pharmacopeia (Ph. Eur.) for quality control of [Tc]Tc-ETIFENIN were considered impractical in routine nuclear medicine services (e.g. time-consuming and difficult to use). Following a literature review and screening phase, a quality control method was selected using a two-strip method. For detection and quantification of [Tc]TcO, a glass microfiber paper impregnated with silica acid (ITLC-SA®) was used with a NaCl 20% mobile phase (w/v). For [Tc]TcO, glass microfiber paper impregnated with silica gel (ITLC-SG®) was used together with an absolute methanol mobile phase. The aim of this work was to validate this alternative analytical method. To do so, the recommendations of the European Association of Nuclear Medicine (EANM), adapted from the International Council of Harmonization Q2 (ICH Q2), were followed. Seven parameters were analyzed: specificity, linearity, precision, accuracy, robustness, limit of quantification and range. Additionally, migration time was also evaluated. This two-strip method appears to be specific (Rs > 2.0), linear (slope close to 1, R ≥ 0.99), precise (CV < 2.0%), accurate (%impurities > %impurities), robust (CV < 2.0%), with an acceptable LoQ (S/N > 10:1) and a wide range (1.6-540 MBq/mL). Time of analysis appears to be clearly integrable into routine clinical practices (< 20 min). The alternative two-strip method NaCl 20% - ITLC-SA® and Methanol - ITLC-SG® represents an efficient quality control procedure. It allows the identification and quantification of the ratios of labelled [Tc]Tc-ETIFENIN together with two potential impurities consisting of [Tc]TcO and [Tc]TcO.
对于肝胆闪烁显像,使用标记有锝-99m的放射性药物依替菲宁(TECHIDA®)作为美布芬宁(CHOLEDIAM®)的替代品。人们普遍认为,放射性药物在注射前应进行检查,特别是通过测定放射化学纯度,以确保获得高质量的图像。放射性色谱技术或产品特性摘要(SmPC)及欧洲药典(Ph. Eur.)中描述的用于[锝]锝-依替菲宁质量控制的方法在常规核医学服务中被认为不实用(例如耗时且难以使用)。经过文献综述和筛选阶段,选择了一种使用两条带方法的质量控制方法。为了检测和定量[锝]锝酸盐,使用浸渍有硅酸的玻璃微纤维纸(ITLC-SA®)和20%氯化钠流动相(w/v)。对于[锝]锝酸盐,使用浸渍有硅胶的玻璃微纤维纸(ITLC-SG®)和无水甲醇流动相。这项工作的目的是验证这种替代分析方法。为此,遵循了欧洲核医学协会(EANM)根据国际协调理事会Q2(ICH Q2)改编的建议。分析了七个参数:特异性、线性、精密度、准确度、稳健性、定量限和范围。此外,还评估了迁移时间。这种两条带方法似乎具有特异性(Rs>2.0)、线性(斜率接近1,R≥0.99)、精密(CV<2.0%)、准确(%杂质>%杂质)、稳健(CV<2.0%),定量限可接受(S/N>10:1)且范围宽(1.6 - 540 MBq/mL)。分析时间似乎可以明确整合到常规临床实践中(<20分钟)。替代的两条带方法20%氯化钠 - ITLC-SA®和甲醇 - ITLC-SG®代表了一种有效的质量控制程序。它可以识别和定量标记的[锝]锝-依替菲宁与两种潜在杂质([锝]锝酸盐和[锝]锝酸盐)的比例。